Is Mohini Health overvalued or undervalued?

As of 13 November 2025, the valuation grade for Mohini Health has moved from fair to expensive, indicating a shift in perception regarding its market value. The company is currently assessed as overvalued. Key ratios include a PE ratio of 14.65, an EV to EBITDA of 9.13, and a Price to Book Value of 0.82, which suggest that while the earnings relative to price are moderate, the overall valuation metrics do not support a favorable investment case at this time.
In comparison to its peers, Mohini Health's PE ratio of 14.65 is significantly lower than Altius Telecom's very attractive PE of 51.84, highlighting a stark contrast in valuation. Additionally, the EV to EBITDA ratio of 9.13 is less favorable when compared to the industry averages, indicating that Mohini Health may not be positioned competitively within its sector. Furthermore, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -7.39% compared to the Sensex's 9.45%, reinforcing the notion that the stock is currently overvalued.